It’s just over a year since Tissuemed gained regulatory approval for TissuePatch in China, making it the first and only surgical sealant to be allowed onto the market in this vast country. Only appropriate then that CEO David Mandley should mark the anniversary with a visit to spend time with Tissuemed’s distributing partner and meet clinicians who are already using TissuePatch. During his week-long stay David has met customers of several specialities in some mightily impressive hospitals across the country. Pictured top is just one of the many hugely impressive facilities visited, this one in Zhengzhou, from where David then headed to meet the Director of Neurosurgery at the Sir Run Run Hospital in Hangzhou.
David commented; “It’s exciting to be here and see plenty of examples of early success. Our partners are doing a great job and being here only reinforces the potential for the only surgical sealant available to these surgeons. The size of the hospitals, the number of clinicians and the breadth of our regulatory approval all mean this is a huge challenge as much as it is an opportunity, but it’s incredibly exciting and the early signs are very encouraging.”
Tissuemed has distributors around the world. If you would like to find out who they are and how they can help you, please complete the short form here.